International Society for the Study of Women's Sexual Health

NEWS

FDA announced a Public Advisory Committee Meeting

FDA announced a Public Advisory Committee Meeting to review the approval of flibanserin for hypoactive sexual desire disorder (HSDD) in women on June 4, 2015. Should you wish to submit your written comments or request time at the public microphone, the deadline is a week away. Please find all details in the Federal Register Notice by clicking on this link. - -

Save the Date

ISSWSH Fall Course 2018
November 15-17, 2018   114 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH / ISSM Joint Meeting 2019
March 7-10, 2019   226 days left
Atlanta, GA, USA

Latest Tweets

Physiotherapy for pelvic pain and female sexual dysfunction: an untapped resource https://t.co/Q043F2YJOm. Encourag… https://t.co/6vDWxSzXvL ISSWSH
Pelvic exam is essential to the accurate diagnosis and treatment of #FSD, but it has a complicated history https://t.co/YTOy3eSbtJ ISSWSH
Check out these great books focusing on women's sexuality and #sexualhealth @ISSWSH https://t.co/gh0S07A5uk ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.